Volume 12, Issue 1 (Jan-Mar 2007)

 BUON in MEDLINE/Pubmed – Editorial (pages 7 to 7)

A. E. Athanassiou (Dept of Medical Oncology-A, Metaxa Cancer Hospital, Piraeus, Greece)

The critical recommendation for the treatment of melanoma patients: Primum nil nocere – Editorial (pages 9 to 10)

U. R. Kleeberg (Hamatologisch-Onkologische Praxis Altona (HOPA), Stuenseehaus, Hamburg, Germany)

Interventional pulmonology techniques for immediate desobstruction of malignant central airway obstruction (pages 11 to 22)

B. Zari (Institute for Pulmonary Diseases of Vojvodina, Medical Faculty, University of Novi Sad, Serbia), V. anak, T. arev, M. Markovi, S. Jovanovi, E. Budiin

Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer (pages 23 to 27)

J. D. Spiliotis (Department of Surgery, Messologi General Hospital, Messologi, Greece), A. C. Datsis

Systemic treatment of melanoma quo vadis oncologist (pages 29 to 32)

S. Retsas (Oncology Centre, Cromwell Hospital, London, United Kingdom)

Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer preliminary results of a phase II study (pages 33 to 39)

P. Rusu (Department of Radiotherapy, Institute of Oncology Prof. Ion Chiricuta, Cluj – Napoca, Romania), T. E. Ciuleanu, D. Cernea, D. Pelau, V. Gaal, C. Cebotaru, T. Guttman, N. Todor, N. Ghilezan

Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients (pages 41 to 44)

M. Dadacaridou (Department of Haematology, Metaxa Cancer Hospital, Piraeus, Greece), X. Papanicolaou, D. Maltesas, C. Megalakaki, P. Patos, K. Panteli, P. Repousis, C. Mitsouli-Mentzikof

Large bowel endoscopy and management of colorectal cancer and its premalignant forms – endoscopy survey (pages 45 to 51)

N. Braykov (Department of Endoscopy and LASER Therapy, National Oncology Centre, Sofia, Bulgaria), V. L. Iordanov

Flexible hysteroscopy in irregular uterine bleeding (pages 53 to 56)

V. Zlatkov (Clinic of Gynecology, National Transport Hospital King Boris III, Sofia, Bulgaria), P. Kostova, G. Barzakov, A. Tcholakova, V. Milochov, E. Velinov, V. Radeva, A. Mihova

Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy (pages 57 to 63)

Y. Kornovski (Medical University-Varna, St. Anna Hospital, Clinic of Gynecology, Varna, Bulgaria), G. Gorchev

Cancer incidence among bulgarian medical radiation workers epidemiological study (pages 65 to 69)

N. Chobanova (National Center of Radiobiology and Radiation Protection, Sofia, Bulgaria), M. Vukov, A. Yagova

Comparison between CoFactor and Leucovorin activity applied in combination with 5-fl uorouracil against two human colon cancer cell lines (pages 71 to 76)

S. K. Bjelogrli (Department of Experimental Pharmacology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia), T. Srdi, S. Radulovi

Deregulated sequential motion of centromeres induced by antitumor agents may lead to genome instability in human peripheral blood lymphocytes (pages 77 to 83)

V. Bajic (Institute for Biomedical Research, Galenika a.d., Belgrade, Serbia), B. Spremo-Potparevic, Z. Milicevic, L. Zivkovic

Microsatellite instability in Bulgarian patients with endometrial cancer (pages 85 to 89)

D. V. Konstantinova (Laboratory of Molecular Pathology, University Hospital of Obstetrics and Gynecology Maichin Dom, Sofia, Bulgaria), T. K. Kadiyska, R. P. Kaneva, S. I. Ivanov, R. G. Dimitrov, T. V. Dyankova, K. P. Meinhardt, M. V. Gulubova, T. I. Vlaykova, N. I. Doganov, V. I. Mitev, I. M. Kremensky

HER-2 expression in uterine cervix carcinogenesis (pages 91 to 97)

Z. Protrka (Department of Obstetrics and Gynecology, Institute of Microbiology and Immunology, Faculty of Medicine,University of Kragujevac, Kragujevac, Serbia), S. Mitrovi, N. Arsenijevi, D. Baski, G. Radosavljevi, M. Stankovi, S. Arsenijevi

Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma (pages 99 to 104)

M. orak (Clinic for Gynecology and Obstetrics, Clinical Centre, Kragujevac, Serbia), S. Arsenijevi, G. Luki, N. Arsenijevi, P. Risti, S. Pavlovi, S. Popovi, D. Baski

Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients (pages 105 to 111)

Zh. Mihaylova (Department of Hematology and Oncology, Military Medical Academy, Sofia, Bulgaria), V. Ludovini, V. Gregorg, I. Floriani, L. Pistola, FR. Toffaneti, M. Ferraldeschi, A. Spreafico, G. L. Ceresoli, M. Bellet, S. Darwish, M. Tonato, J. Raynov

Acute heart failure after treatment with 5-fluorouracil (pages 113 to 116)

S. Georgieva (Oncotherapeutic Clinic, Queen Giovanna Hospital, Sofia, Bulgaria), E. Kinova, V. Iordanov, A. Gudev, V. Tzekova, M. Velikova

Primary classic penile Kaposi’s sarcoma in an elderly HIV-negative patient report of a case and review of the literature (pages 117 to 119)

T. Klimis (Department of Pathology, 3rd Hospital of Social Insurance Foundation, Athens, Greece), A. Margaritopoulou, J. Panopoulos, N. Kokotas

Minimal invasive treatment of cervical rhabdomyosarcoma in an adolescent girl (pages 121 to 123)

Z. B. Stankovic (Mother and Child Health Institute of Serbia, Belgrade, Serbia), S. Djurii, D. S. Stankovi, S. Zdravkovi, S. Gazikalovi, K. Sedlecki

Primary solitary eosinophilic granuloma of the brain and postoperative radiotherapy A clinical case (pages 125 to 128)

L. Mihova (Department of Radiotherapy and Nuclear Medicine, University Hospital St. George Plovdiv, Plovdiv, Bulgaria), M. Yaneva, M. Sopadjieva, V. Andreev, I. Nejtcheva

Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer case report with literature review (pages 129 to 132)

J. Grudeva-Popova (Clinic of Hematology, University Hospital, Plovdiv, Bulgaria), M. Yaneva, K. Zisov, N. Ananoshtev

JBUON and important biomedical databases – Letter to editor (pages 133 to 133)

L. Vuckovic-Dekic (Institute for Oncology and Radiology of Serbia, Belgrade, Serbia)

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients – Letter to editor (pages 135 to 136)

A. Eroglu (Department of General Surgery and Surgical Oncology, Numune State Hospital, Konya, Turkey), A. Ulu, R. Cam, N. Akar

If Jules Verne had a stage IV lung cancer; a science fiction solution of cancer – Letter to editor (pages 137 to 138)

M. Kaptanoglu (Dept of Thoracic Surgery, Faculty of Medicine, Cumhuriet University, Sivas, Turkey)

Professor Miltiades Papamiltiades (1907-1987) 20 years since the death of an eminent Greek anatomopathologist and cytologist (pages 139 to 144)

G. Androutsos (Department of History of Medicine, Faculty of Medicine, University of Ioannina, Greece)